Development of a structured process for the Spanish translation of the 2021 ACNS standardized critical care EEG terminology (P4-8.010)

Abstract

<h3>Objective:</h3> To develop a Spanish translation of the 2021 critical care EEG terminology through a structured consensus of an interdisciplinary group with representation from Latin America and Spain. <h3>Background:</h3> Aiming for a common language for the classification of electroencephalogram (EEG) findings in critical care (ICU), the American Clinical Neurophysiology Society (ACNS) published the ICU-EEG terminology in 2013, which was updated in 2021. Since this nomenclature has not been published in Spanish, the potential use of the ICU-EEG terminology can be variable when translated into daily practice in Spanish-speaking countries. <h3>Design/Methods:</h3> The initial translation of the terminology was done in parallel by three subgroups of Spanish-speaking neurophysiologists and neurointensivists representing different regions of Latin America and Spain. Each subgroup worked iteratively on one section of the terminology. Scheduled meetings were carried out with the entire team to discuss translation differences and alternatives, which were recorded for discussion in future planned consensus groups. We have recruited 25 participants from Latin America and Spain to explore their impressions on the applicability, implementation, and regional differences of the translation in different Spanish-speaking countries. Using qualitative methodology, the consensus groups will follow nominal group technique methods. <h3>Results:</h3> The process, common discussion points, and consensus agreements and disagreements of the different terms chosen in the translation will be presented. <h3>Conclusions:</h3> The Spanish language is diverse, and the terms used to describe electroencephalographic findings vary in different countries. It is essential to consider these variations when translating guidelines into other languages. Translations need to be structured, iterative, and consensus-based with representations of different countries with the same language to encourage widespread use and a more homogeneous communication, which can in turn facilitate and encourage future research. <b>Disclosure:</b> Dr. Bruzzone has nothing to disclose. Dr. Rubinos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Qualtrics Inc. Dr. Rubinos has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for American Epilepsy Society . The institution of Dr. Rubinos has received research support from University of North Carolina . Dr. Lowden has nothing to disclose. Dr. Appendino has nothing to disclose. Dr. Vidaurre has nothing to disclose. Daniel San Juan-Orta has nothing to disclose. Dr. Garcia Losarcos has nothing to disclose. Dr. Villamar has a non-compensated relationship as a Member of Editorial Board with Neurology: Clinical Practice that is relevant to AAN interests or activities. Dr. Villamar has a non-compensated relationship as a Member of Editorial Board with The Neurohospitalist that is relevant to AAN interests or activities. Dr. Burneo has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier, Clinical Neurology and Neurosurgery Journal. Dr. Burneo has received research support from The Jack Cowin Endowed Chair in Epilepsy Research. Dr. Burneo has received publishing royalties from a publication relating to health care. Dr. Mayor has nothing to disclose. Dr. Rodriguez-Ruiz has received personal compensation in the range of $0-$499 for serving as a Consultant for Atheneum. Dr. Rodriguez-Ruiz has stock in Lourbeth LLC. Dr. Gutierrez has nothing to disclose. Dr. Fernandez has nothing to disclose.